Katja Roth Pellanda, Ph.D., has been Secretary to the Executive Committee of Novartis since February 1, 2018. She also serves as Head of Corporate Law and Corporate Governance.
Ms. Roth Pellanda joined Novartis in 2015 as Head of Corporate Law. Prior to that, she was a senior associate at Bär & Karrer Ltd. in Zurich, Switzerland, from 2009 to 2015, and an associate from 2005 to 2008. She previously served as a research and teaching assistant at the University of Zurich, Faculty of Law, and in 2004, she was a visiting researcher at Stanford University in the United States. Her areas of specialization include corporate law, with an emphasis on corporate governance; mergers and acquisitions transactions; corporate restructurings; and security and employment laws.
After being admitted to the Basel bar in 2002, Ms. Roth Pellanda received her Master of Laws in banking and financial regulation from the London School of Economics in the United Kingdom, and her doctorate in law from the University of Zurich. She regularly publishes in her fields of experience.